Literature DB >> 11986378

Mechanisms and physiological role of enhancement of mGlu5 receptor function by group II mGlu receptor activation in rat perirhinal cortex.

K Cho1, M W Brown, Z I Bashir.   

Abstract

In this study we have investigated mechanisms underlying enhancement by group II metabotropic glutamate (mGlu) receptors of group I mGlu receptor-induced calcium mobilization. Inhibition of protein kinase A (PKA) caused an enhancement of mGlu5 receptor-mediated calcium mobilization and occluded the enhancement by group II mGlu receptors. A peptide (Ht31) that prevents interaction between A-kinase anchoring protein (AKAP) and PKA also enhanced mGlu5-mediated calcium mobilization. Enhancement of mGlu5 function, by inhibition of PKA or by activation of group II mGlu receptors, was prevented by the protein phosphatase 2B (PP2B) inhibitor cyclosporin A. Furthermore, the enhancement by activation of group II mGlu receptors was prevented by raising intracellular cAMP. These results suggest that the regulation by PKA and PP2B of phosphorylation of a substrate on mGlu5 and/or on group II mGlu receptors is intimately involved in the mechanisms underlying interaction between group II mGlu and mGlu5 receptors. Long-term depression (LTD) in perirhinal cortex requires group I, group II and NMDA receptor activation at resting membrane potentials but does not require group II mGlu receptor activation at depolarized potentials. We previously suggested that interaction between group I and group II mGlu receptors is required for induction of LTD at resting potentials. In support of this, we demonstrate in perirhinal cortex slices that blocking mechanisms underlying mGlu receptor synergy (by raising intracellular cAMP or by inhibition of PP2B) selectively prevented LTD at resting membrane potentials. This study thus provides a potential explanation for the co-requirement in LTD of group I and group II mGlu receptor activation. Similar mechanisms of synergistic interaction may also be important in other physiological processes dependent on mGlu receptors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11986378      PMCID: PMC2290277          DOI: 10.1113/jphysiol.2001.013920

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  31 in total

1.  A new form of long-term depression in the perirhinal cortex.

Authors:  K Cho; N Kemp; J Noel; J P Aggleton; M W Brown; Z I Bashir
Journal:  Nat Neurosci       Date:  2000-02       Impact factor: 24.884

Review 2.  AKAPs: from structure to function.

Authors:  M Colledge; J D Scott
Journal:  Trends Cell Biol       Date:  1999-06       Impact factor: 20.808

3.  Antagonism of the mGlu5 agonist 2-chloro-5-hydroxyphenylglycine by the novel selective mGlu5 antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) in the thalamus.

Authors:  T E Salt; K E Binns; J P Turner; F Gasparini; R Kuhn
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

4.  Involvement of a postsynaptic protein kinase A substrate in the expression of homosynaptic long-term depression.

Authors:  K Kameyama; H K Lee; M F Bear; R L Huganir
Journal:  Neuron       Date:  1998-11       Impact factor: 17.173

5.  Protein kinase A-anchoring inhibitor peptides arrest mammalian sperm motility.

Authors:  S Vijayaraghavan; S A Goueli; M P Davey; D W Carr
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

6.  Potentiation of a metabotropic glutamatergic response following NMDA receptor activation in rat hippocampus.

Authors:  A Lüthi; B H Gähwiler; U Gerber
Journal:  Pflugers Arch       Date:  1994-05       Impact factor: 3.657

7.  cAMP-dependent protein kinase inhibits mGluR2 coupling to G-proteins by direct receptor phosphorylation.

Authors:  H Schaffhauser; Z Cai; F Hubalek; T A Macek; J Pohl; T J Murphy; P J Conn
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

8.  2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist.

Authors:  F Gasparini; K Lingenhöhl; N Stoehr; P J Flor; M Heinrich; I Vranesic; M Biollaz; H Allgeier; R Heckendorn; S Urwyler; M A Varney; E C Johnson; S D Hess; S P Rao; A I Sacaan; E M Santori; G Veliçelebi; R Kuhn
Journal:  Neuropharmacology       Date:  1999-10       Impact factor: 5.250

9.  An essential role for protein phosphatases in hippocampal long-term depression.

Authors:  R M Mulkey; C E Herron; R C Malenka
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

10.  Inhibition of dopamine agonist-induced phosphoinositide hydrolysis by concomitant stimulation of cyclic AMP formation in brain slices.

Authors:  A S Undie; E Friedman
Journal:  J Neurochem       Date:  1994-07       Impact factor: 5.372

View more
  9 in total

1.  AKAP150, a switch to convert mechano-, pH- and arachidonic acid-sensitive TREK K(+) channels into open leak channels.

Authors:  Guillaume Sandoz; Susanne Thümmler; Fabrice Duprat; Sylvain Feliciangeli; Joëlle Vinh; Pierre Escoubas; Nicolas Guy; Michel Lazdunski; Florian Lesage
Journal:  EMBO J       Date:  2006-11-16       Impact factor: 11.598

Review 2.  Neurotransmitter receptor expression and activity during neuronal differentiation of embryonal carcinoma and stem cells: from basic research towards clinical applications.

Authors:  H Ulrich; P Majumder
Journal:  Cell Prolif       Date:  2006-08       Impact factor: 6.831

Review 3.  How do barrels form in somatosensory cortex?

Authors:  Hong Li; Michael C Crair
Journal:  Ann N Y Acad Sci       Date:  2011-04       Impact factor: 5.691

4.  Mechanisms of memory storage in a model perirhinal network.

Authors:  Pranit Samarth; John M Ball; Gunes Unal; Denis Paré; Satish S Nair
Journal:  Brain Struct Funct       Date:  2016-03-12       Impact factor: 3.270

5.  Dopaminergic modulation of the hippocampal neuropil proteome identified by bioorthogonal noncanonical amino acid tagging (BONCAT).

Authors:  Jennifer J L Hodas; Anne Nehring; Nicole Höche; Michael J Sweredoski; Rainer Pielot; Sonja Hess; David A Tirrell; Daniela C Dieterich; Erin M Schuman
Journal:  Proteomics       Date:  2012-08       Impact factor: 3.984

6.  Co-incident signalling between mu-opioid and M3 muscarinic receptors at the level of Ca2+ release from intracellular stores: lack of evidence for Ins(1,4,5)P3 receptor sensitization.

Authors:  Damien S K Samways; Wen-hong Li; Stuart J Conway; Andrew B Holmes; Martin D Bootman; Graeme Henderson
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

7.  The potential of caffeine for functional modification from cortical synapses to neuron networks in the brain.

Authors:  Hiroshi Yoshimura
Journal:  Curr Neuropharmacol       Date:  2005-10       Impact factor: 7.363

8.  A temporally distinct role for group I and group II metabotropic glutamate receptors in object recognition memory.

Authors:  Gareth Robert Isaac Barker; Zafar Iqbal Bashir; Malcolm Watson Brown; Elizabeth Clea Warburton
Journal:  Learn Mem       Date:  2006 Mar-Apr       Impact factor: 2.460

9.  Frontal cortex genetic ablation of metabotropic glutamate receptor subtype 3 (mGlu3) impairs postsynaptic plasticity and modulates affective behaviors.

Authors:  Max E Joffe; Chiaki I Santiago; Sheryl Anne D Vermudez; Nicole M Fisher; Shalini Dogra; Colleen M Niswender; P Jeffrey Conn
Journal:  Neuropsychopharmacology       Date:  2021-05-25       Impact factor: 7.853

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.